Rendering

Component: (Network and Table)
Network
2415404 - Disclosure - Shareholders Equity (Schedule Of Changes In Non-Vested Restricted Shares) (Details)
(http://www.amsurg.com/role/ShareholdersEquityScheduleOfChangesInNonVestedRestrictedSharesDetails)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0000895930 (http://www.sec.gov/CIK)
Equity [Abstract]Period [Axis]
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
2013-01-01 - 2013-12-31
Equity [Abstract]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
 
 
 
Non-vested shares at beginning of period, Number of Shares
668,109  
743,869  
828,686  
Shares granted, Number of Shares
313,498  
272,780  
291,863  
Shares vested, Number of Shares
(233,831) 
(336,160) 
(360,337) 
Shares forfeited, Number of Shares
(13,675) 
(12,380) 
(16,343) 
Non-vested shares at end of period, Number of Shares
734,101  
 
668,109  
 
743,869  
 
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
 
 
 
Non-vested shares at beginning of period, Weighted Average Grant Price (usd per share)
33.51  
26.54  
22.50  
Shares granted, Weighted Average Grant Price (usd per share)
56.19  
43.12  
31.66  
Shares vested, Weighted Average Grant Price (usd per share)
28.19  
25.69  
21.55  
Shares forfeited, Weighted Average Grant Price (usd per share)
42.15  
38.94  
23.11  
Non-vested shares at end of period, Weighted Average Grant Price (usd per share)
44.73  
33.51  
26.54